# Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

> **NCT00490035** · PHASE3 · COMPLETED · sponsor: **UCB Pharma SA** · enrollment: 399 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **OTHER:** Placebo
- **DRUG:** Brivaracetam
- **DRUG:** Brivaracetam
- **DRUG:** Brivaracetam

## Key facts

- **NCT ID:** NCT00490035
- **Lead sponsor:** UCB Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 399 (ACTUAL)
- **Last updated:** 2022-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490035, "Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00490035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*